Shay L. Bellasea

机构：Fred Hutch Cancer Center, Data Management (Italy) · ORCID：0009-0008-5934-6715

发表论文 32 篇 · 总被引 280 次 · h-index 5

代表论文

• Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial (2023 · Nature Medicine · 被引 178)
• Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial (2025 · Nature Medicine · 被引 7)
• Abstract 3275: Combination of talimogene laherparepvec (T-VEC) with pembrolizumab (pembro) in advanced melanoma patients following progression on a prior PD-1 inhibitor: SWOG S1607 (2023 · Cancer Research · 被引 5)
• Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial (2026 · Nature Cancer · 被引 4)
• SWOG 2308: Randomized Phase III Study of Mosunetuzumab Versus Rituximab for Low–Tumor Burden Follicular Lymphoma (2025 · JCO oncology advances. · 被引 4)
• Abstract CT009: S1512: High response rate with single agent anti-PD-1 in patients with metastatic desmoplastic melanoma (2023 · Cancer Research · 被引 3)